Nearly 5 years after the controversial Proposition 71 was voted into law, and with very little concrete progress to show for it, scientists are reevaluating the field of embryonic stem cell research in California.
The company Neuralstem has been awarded a patent for its proprietary technology to immortalize human neural stem cells.
The biotech company Geron has received FDA approval to conduct the first human clinical trial with embryonic stem cells.
Opexa Therapeutics holds an informative briefing on both executive and scientific company news.
The Australia-based company Mesoblast Limited announces institutional approval to begin the first human clinical trials of adult stem cell treatment for the prevention of osteoarthritis in the knee after acute traumatic injury.
In a controversial ruling, the Scottish company ReNeuron has received authorization to conduct a clinical trial in which patients will be treated for corneal blindness with stem cells harvested from aborted human fetuses.
Toll Free:
1-800-980-STEM (7836)
Outside or Inside US Call:
1-954-358-3382
Toll Free Fax (US Only):
1-866-755-3951
From Outside US Fax:
1-775-887-1194
Copyright 2025, Stem Cell Insitute Panama. All rights reserved.